Surrogate Markers of Efficacy For Medical Treatment of Viral Hepatitis

Por Block, Timothy M., London, W. Thomas
Publicado em 2004

Can Propranalol Prevent Hepatocellular Carcinoma?

Por London, W. Thomas, McGlynn, Katherine A.
Publicado em 2012

The Global Epidemiology of Hepatocellular Carcinoma, Present and Future

Por McGlynn, Katherine A., London, W. Thomas
Publicado em 2011

THE NATURE OF AUSTRALIA ANTIGEN AND ITS RELATION TO ANTIGEN-ANTIBODY COMPLEX FORMATION

Por Blumberg, Baruch S., Millman, Irving, Sutnick, Alton I., London, W. Thomas
Publicado em 1971

Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability

Por McGlynn, Katherine A., Petrick, Jessica L., London, W. Thomas
Publicado no Clin Liver Dis (2015)

Quantification of complex precore mutations of hepatitis B virus by SimpleProbe real time PCR and dual melting analysis

Por Nie, Hui, Evans, Alison A., London, W. Thomas, Block, Timothy M., Ren, Xiangdong David
Publicado em 2011

Ultrasensitive Quantification of Hepatitis B Virus A1762T/G1764A Mutant by a SimpleProbe PCR Using a Wild-Type-Selective PCR Blocker and a Primer-Blocker-Probe Partial-Overlap Appr...

Por Nie, Hui, Evans, Alison A., London, W. Thomas, Block, Timothy M., Ren, Xiangdong David
Publicado em 2011

Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion

Por Nie, Hui, Evans, Alison A., London, W. Thomas, Block, Timothy M., Ren, Xiangdong David
Publicado em 2011

DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome

Por Agarwal, S. S., Blumberg, Baruch S., Gerstley, Betty Jane S., London, W. Thomas, Sutnick, Alton I., Loeb, Lawrence A.
Publicado em 1970

Chronic hepatitis B: What should be the goal for new therapies?

Por Block, Timothy M., Gish, Robert, Guo, Haitao, Mehta, Anand, Cuconati, Andrea, London, W. Thomas, Guo, Ju-Tao
Publicado em 2013

A Proteomic Approach for the Discovery of Early Detection Markers of Hepatocellular Carcinoma

Por Steel, Laura F., Mattu, Taj S., Mehta, Anand, Hebestreit, Holger, Dwek, Raymond, Evans, Alison A., London, W. Thomas, Block, Timothy
Publicado em 2001

Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink

Por McGlynn, Katherine A., Hagberg, Katrina, Chen, Jie, Graubard, Barry I., London, W. Thomas, Jick, Susan, Sahasrabuddhe, Vikrant V.
Publicado no J Natl Cancer Inst (2015)

Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care

Por McMahon, Brian, Block, Joan, Block, Timothy, Cohen, Chari, Evans, Alison A., Hosangadi, Anu, London, W. Thomas, Sherman, Morris
Publicado no J Natl Cancer Inst (2015)

Dichlorodiphenyltrichloroethane (DDT) and risk of hepatocellular carcinoma

Por Persson, E. Christina, Graubard, Barry I., Evans, Alison A., London, W. Thomas, Weber, Jean-Philippe, LeBlanc, Alain, Chen, Gang, Lin, Wenyao, McGlynn, Katherine A.
Publicado em 2012

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans

Por Block, Timothy M., Comunale, Mary Ann, Lowman, Melissa, Steel, Laura F., Romano, Patrick R., Fimmel, Claus, Tennant, Bud C., London, W. Thomas, Evans, Alison A., Blumberg, Baruch S., Dwek, Raymond A., Mattu, Tajinder S., Mehta, Anand S.
Publicado em 2005

Fumonisin B(1) and Risk of Hepatocellular Carcinoma in Two Chinese Cohorts

Por Persson, E. Christina, Sewram, Vikash, Evans, Alison A., London, W. Thomas, Volkwyn, Yvette, Shen, Yen-Ju, Van Zyl, Jacobus A., Chen, Gang, Lin, Wenyao, Shephard, Gordon S., Taylor, Philip R., Fan, Jin-Hu, Dawsey, Sanford M., Qiao, You-Lin, McGlynn, Katherine A., Abnet, Christian C.
Publicado em 2011